Breast Cancer Research and Treatment

, Volume 124, Issue 3, pp 701–705

Primary systemic therapy for operable breast cancer patients: the need for the new generation of trial design

Invited Commentary

DOI: 10.1007/s10549-010-1212-5

Cite this article as:
Alvarez, R.H. & Hortobagyi, G.N. Breast Cancer Res Treat (2010) 124: 701. doi:10.1007/s10549-010-1212-5

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  1. 1.Department of Breast Medical OncologyThe University of Texas MD Anderson Cancer CenterHoustonUSA